Jefferies Group's UTHR Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 9,149 shares of United Therapeutics Corporation (UTHR) worth $4.46 M, representing 0.02% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 7 quarters.
Based on 13F filings, Jefferies Group has maintained this position in UTHR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2023, adding 10,385 shares. Largest reduction occurred in Q3 2024, reducing 5,700 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's United Therapeutics Corporation (UTHR) Holding Value Over Time
Track share changes against reported price movement
Quarterly United Therapeutics Corporation (UTHR) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +1,440 | New Buy | 1,440 | $223.96 |
| Q2 2023 | -1,440 | Sold Out | 0 | $0.00 |
| Q4 2023 | +10,385 | New Buy | 10,385 | $219.89 |
| Q1 2024 | -385 | Reduce 3.71% | 10,000 | $229.72 |
| Q2 2024 | -4,300 | Reduce 43.00% | 5,700 | $318.55 |
| Q3 2024 | -5,700 | Sold Out | 0 | $0.00 |
| Q4 2025 | +9,149 | New Buy | 9,149 | $487.25 |
Jefferies Group's United Therapeutics Corporation Investment FAQs
Jefferies Group first purchased United Therapeutics Corporation (UTHR) in Q1 2023, acquiring 1,440 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held United Therapeutics Corporation (UTHR) for 7 quarters since Q1 2023.
Jefferies Group's largest addition to United Therapeutics Corporation (UTHR) was in Q4 2023, adding 10,385 shares worth $2.28 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 9,149 shares of United Therapeutics Corporation (UTHR), valued at approximately $4.46 M.
As of the Q4 2025 filing, United Therapeutics Corporation (UTHR) represents approximately 0.02% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in United Therapeutics Corporation (UTHR) was 10,385 shares, as reported at the end of Q4 2023.